Brief: Acurx Pharmaceuticals, Inc. Announces Pricing Of $4.0 Million Registered Direct Offering
16/05/2023 14:28
Acurx Pharmaceuticals Inc ACXP.O :
* ACURX PHARMACEUTICALS, INC. ANNOUNCES PRICING OF $4.0
MILLION
REGISTERED DIRECT OFFERING
* ACURX PHARMACEUTICALS: AGREEMENT WITH A SINGLE
INSTITUTIONAL
INVESTOR TO BUY 1.3 MILLION SHARES AT COMBINED EFFECTIVE
PURCHASE PRICE OF $3.00 PER SHARE
Source text for Eikon: ID:nPn8VBBwKa
Further company coverage: ACXP.O
Recent news on Acurx Pharmaceuticals
See all newsAcurx Pharmaceuticals Q1 net loss narrows as expenses fall
Brief: Acurx Pharmaceuticals To Discuss First Quarter 2026 Financial Results On May 12, 2026 Conference Call And Provide Business Update
Brief: Acurx Pharmaceuticals, Inc. Announces Closing Of Up To $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Acurx Pharmaceuticals Q4 net loss narrows on lower R&D spend
Acurx Pharma Q3 net loss narrows to $2 mln